BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
67 hedge funds and large institutions have $20.7M invested in Bellicum Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 26 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
60% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 20
Holders
67
Holding in Top 10
–
Calls
$301K
Puts
$33K
Top Buyers
| 1 | +$1.09M | |
| 2 | +$1.09M | |
| 3 | +$788K | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$263K |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$263K |
Top Sellers
| 1 | -$3.27M | |
| 2 | -$946K | |
| 3 | -$708K | |
| 4 |
Jane Street
New York
|
-$411K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$340K |